Transdermal Testosterone Gel/Effect on Erection Quality as Measured by DIR
The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2007 by Lamm, Steven, M.D..
Recruitment status was Recruiting
Information provided by:
Lamm, Steven, M.D.
First received: January 20, 2007
Last updated: January 22, 2007
Last verified: January 2007
Low testosterone may be responsible for "soft" erections in men. The purpose of our study is to see whether the daily application of a testosterone gel to raise testosterone levels will also increase the "hardness" of a man's erection.
Drug: AndroGel (Transdermal Testosterone Gel)
||Observational Model: Defined Population
Time Perspective: Cross-Sectional
||Phase I Study of Transdermal Testosterone Gel and Its Effect on Erection Quality as Measured by a Digital Inflection Rigidometer (DIR)
| Estimated Enrollment:
| Study Start Date:
|Ages Eligible for Study:
||21 Years to 59 Years
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
- Testosterone <350 ng/dL,
- 21-59 years of age,
- BMI <30
- Those with carcinoma of the breast or known or suspected carcinoma of the prostate or with known hypersensitivity to any of the ingredients in AndroGel.
- Men will be excluded if they have unstable angina, hypertension, diabetes, heart failure, or coronary artery disease.
- Men will agree to discontinue use of current testosterone replacement, as well as Viagra or any other PDE5 inhibitors for 30 days.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00425568
|Steven Lamm, M.D.
|New York, New York, United States, 10028 |
|Contact: Steven Lamm, M.D. 212-988-1146 firstname.lastname@example.org |
|Principal Investigator: Steven Lamm, M.D. |
Lamm, Steven, M.D.
||Steven Lamm, M.D.
No publications provided
History of Changes
|Other Study ID Numbers:
|Study First Received:
||January 20, 2007
||January 22, 2007
||United States: Institutional Review Board
Keywords provided by Lamm, Steven, M.D.:
low testosterone level
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on March 06, 2014
Endocrine System Diseases
Testosterone 17 beta-cypionate
Hormones, Hormone Substitutes, and Hormone Antagonists
Physiological Effects of Drugs
Antineoplastic Agents, Hormonal